Presenting Visual Acuity and Ocular Comorbidity in Patients with Primary Open Angle Glaucoma in a Private Tertiary Eye Center in Nigeria
Roseline Duke, Ayodele Akinye, Soter Ameh
Ocular comorbidity, Visual acuity, Primary open angle glaucoma
Citation Information :
Duke R, Akinye A, Ameh S. Presenting Visual Acuity and Ocular Comorbidity in Patients with Primary Open Angle Glaucoma in a Private Tertiary Eye Center in Nigeria. J Curr Glaucoma Pract 2013; 7 (1):6-10.
Purpose: To determine the presenting visual acuity (VA) of patients with primary open angle glaucoma (POAG) and the relationship to ocular comorbidity.
Materials and methods: A retrospective case note audit was undertaken in Eye Foundation Hospital, Calabar, between 1st January 2010 and 31st June 2011. The case notes of all newly presenting patients diagnosed with POAG were retrieved and data were extracted for analysis. Inclusion criteria for glaucoma was defined.
Results: Out of a total of 320 new patients, 88 patients were diagnosed with POAG, with a prevalence of 27.5% (95% CI: 22.7-32.7). The mean age for males is 57.1 ± 8.8 while that of females is 52.6 ± 11.2 and the total mean of 55.8 ± 9.7. Of the 88 patients, there were 84 self referrals [95.5% (95% CI: 88.8-98.7)], of these, 45, 53.6% (95% CI: 42.4-64.5) were for second opinion. There was no statistical significance between the gender, education and occupation and the level of VA seen on presentation.
The best corrected visual acuity (BCVA) in the right and left eye respectively, was significantly (p < 0.0001) related to the cup disk ratio. Ocular comorbid conditions were seen in 19 (22%) patients in the study. The presenting BCVA was significantly related to the presence of ocular comorbidity in the best eye. Comorbidity was not strongly related to the age of the patients.
Conclusion: The course of glaucomatous progression is highly variable, identifying factors that not only predict progression but influence the VA and ocular health of the eye can help to guide clinical practice and patient treatment and monitoring.
Rabiu MM, Kyari F, Ezelum C, Elhassan E, Sanda S, Murthy GV, Sivasubramaniam S, Glibert C, Abdull MM, Abiose A. Review of the publications of the Nigeria national blindness survey: methodology, prevalence, causes of blindness and visual impairment and outcome of cataract surgery. Ann Afr Med 2012 Jul-Sep;11(3):125-130.
Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996 May;80(5):389-393.
Thylefors B, Negrel AD. The global impact of glaucoma. Bull World Health Organ 1994;72(3):323-326.
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006 Mar;90(3):262-267.
Ashaye, AO. 12th Faculty of Ophthalmology Lecture, National Postgraduate Medical College of Nigeria 2010. Glaucoma blindness: facts, fancies and fables. [place unknown]: [publisher unknown]; [date unknown]. p. 20.
Varma R, Tielsch JM, Quigley HA, Hilton SC, Katz J, Spaeth GL, Sommer A. Race-, age-, gender- and refractive error-related differences in the normal optic disc. Arch Ophthalmol 1994 Aug;112(8):1068-1076.
Sathyamangalam RV, Paul PG, George R, Baskaran M, Hemamalini A, Madan RV, Augustian J, Prema R, Lingam V. Determinants of glaucoma awareness and knowledge in urban Chennai. Indian J Ophthalmol 2009 Sep-Oct;57(5):355-360.
Kosoko-Lasaki O, Gong G, Haynatzki G, Wilson MR. Race, ethnicity and prevalence of primary open-angle glaucoma. J Natl Med Assoc 2006 Oct;98(10):1626-1629.
Rotchford AP, Kirwan JF, Muller MA, Johnson GJ, Roux P. Temba glaucoma study: a population-based cross-sectional survey in urban South Africa. Ophthalmology 2003 Feb;110(2):376-382.
Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet 2004 May;363(9422):1711-1720.
Leske MC, Heijl A, Hyman L, Bengtsson B, Komaroff E. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial. Curr Opin Ophthalmol 2004 Apr;15(2):102-106.
Oliver JE, Hattenhauer MG, Herman D, Hodge DO, Kennedy R, Fang-Yen M, Johnson DH. Blindness and glaucoma: a comparision of patients progressing to blindness from glaucoma with patients maintaining vision. Am J Ophthalmol 2002 Jun;133(6):764-772.
Awoyesuku EA, Ejimadu CS. Visual disability in newly diagnosed primary open angle glaucoma (POAG) patients in a tertiary hospital in Nigeria. Niger J Med 2012 Jan-Mar;21(1):78-80.
Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM. Risk factors for noncompliance with glaucoma follow-up visits in a residents’ eye clinic. Ophthalmology 1998 Nov;105(11): 2105-2111.
Luo RJ, Liu SR, Tian Z, Zhu WH, Zhuo YH, Liao RD. Rehabilitation of vision disorder and improved quality of life in patients with primary open angle glaucoma. Chin Med J (Engl) 2011 Sep;124(17):2687-2691.
Pan Y, Varma R. Natural history of glaucoma. Indian J Ophthalmol 2011 Jan;59(Suppl 1): 19S-23S.
Tielsch JM, Somner A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open angle glaucoma. The Baltimore Eye Surgery. JAMA 1991 Jul;266(3):369-374.
Ashaye AO. Clinical features of primary glaucoma in Ibadan. Nig J Ophthalmol 2003;11(2):70-75.